Sitemap
- Patients and Public
- Healthcare professionals and institutions
-
Industry
-
Marketing authorisation holders
- Pre-authorisation
-
Post-authorisation
- Transfer of Marketing Authorisation Holder
- Notifications regarding start of distribution, supply disruptions and price of medicinal products
- Gift of medicinal products
- Multilingual packaging
- Foreign country packaging in Latvia
- Leaving the market
- Requirements for quality control of medicines (including vaccines)
- Pharmacovigilance
- Information regarding marketing authorisation, renewal and withdrawal of marketing authorisation of medicines
- Purchase of statistical data
- Variations to marketing authorisation documentation (announcements)
- Cost-effectivenes assessment
- Information on the granting of exemptions from the Sunset Clause
- Up-to-date information on the decisions made by the Agency of the granting of exemptions from the Sunset Clause
- Evaluation of compliance of a product with the definition of a medicinal product
- Scientific Advice
- Frequently asked questions (FAQ)
- Pharmacies
- Manufacturers of medicines
- Manufacturers, importers and distributors of active substances
-
Wholesalers and brokers
- New wholesaler
- Brokers (brokering of medicinal products)
- List of marketing authorization holders
- Parallel Distribution of Medicinal Products
- Parallel Imported Medicinal Products
- Recognition of special authorisations (licences) issued in the EU or EEA State for the type of business concerned
- Requirements for quality control of medicines (including vaccines)
- Sponsors of clinical trials
- Medical device manufacturers, authorized representatives
- Precursor operators
- Substances controlled in Latvia in research and training
-
Marketing authorisation holders
